OTCMKTS:GRRMF - Gerresheimer Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $88.97
  • Forecasted Upside: 36.54 %
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$65.16
+0.30 (1.20%)

This chart shows the closing price for GRRMF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Gerresheimer Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for GRRMF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for GRRMF

Analyst Price Target is $88.97
▲ +36.54% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Gerresheimer in the last 3 months. The average price target is $88.97, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 36.54% upside from the last price of $65.16.

This chart shows the closing price for GRRMF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 3 contributing investment analysts is to buy stock in Gerresheimer.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/29/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
2/27/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
5/28/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
8/26/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
11/24/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
2/22/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/23/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
5/23/2022

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
4/14/2022Credit Suisse GroupLower Price TargetOutperform ➝ Outperform€89.00 ➝ €86.00
4/12/2022JPMorgan Chase & Co.Lower Price Target€72.20 ➝ €68.90
3/24/2022JPMorgan Chase & Co.Boost Price Target€72.00 ➝ €72.20
1/25/2022JPMorgan Chase & Co.Lower Price Target€86.20 ➝ €80.20
10/13/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy
10/13/2021JPMorgan Chase & Co.Reiterated RatingNeutral
10/13/2021Credit Suisse GroupReiterated RatingOutperform
9/17/2021Deutsche Bank AktiengesellschaftInitiated CoverageBuy$112.00
9/17/2021JPMorgan Chase & Co.Reiterated RatingNeutral
1/29/2021DZ BankReiterated RatingBuy
1/22/2021Pareto SecuritiesDowngradeBuy ➝ Hold
10/19/2020DZ BankReiterated RatingSell
7/29/2020Berenberg BankReiterated RatingBuy
1/2/2019JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight
(Data available from 5/24/2017 forward)

News Sentiment Rating

1.22 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/26/2021
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/25/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/25/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/24/2022
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/23/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/25/2022
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/24/2022
  • 2 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/24/2022

Current Sentiment

  • 2 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.
Gerresheimer logo
Gerresheimer AG, together with its subsidiaries, manufactures and sells packaging products, and drug delivery-devices and solutions worldwide. It operates through Plastics & Devices, Primary Packaging Glass, and Advanced Technologies divisions. The Plastics & Devices division offers drug delivery systems, including inhalers, insulin pen systems, prefillable syringes, and diagnostic systems for the pharma, biotech, diagnostics, and medical technology industries; containers and closures, PET bottles, eye droppers, nasal sprays, nebulizers, applicators, and accessories for solid, liquid, and ophthalmic applications; and bottles and containers for nutritional supplements. The Primary Packaging Glass division offers glass primary packaging for pharma and cosmetics industries, such as infusion, dropper, and syrup bottles; injection vials, ampoules, and cartridges; miniature bottles and glass containers for liquid food, spices, and spirits; and packaging solutions for fragrances, deodorants, skin care, and wellness products, as well as beauty and pharmaceutical products. The Advanced Technologies division develops smart drug delivery systems, such as micro pumps, which are used to self-administer medication for Parkinson's disease or heart failure to pharmaceutical and biotech customers. The company was founded in 1864 and is headquartered in Düsseldorf, Germany.
Read More

Today's Range

Now: $65.16
Low: $65.16
High: $65.16

50 Day Range

MA: $69.20
Low: $65.16
High: $71.46

52 Week Range

Now: $65.16
Low: $65.16
High: $95.70

Volume

N/A

Average Volume

988 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Gerresheimer?

The following Wall Street sell-side analysts have issued research reports on Gerresheimer in the last year: Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, and JPMorgan Chase & Co..
View the latest analyst ratings for GRRMF.

What is the current price target for Gerresheimer?

0 Wall Street analysts have set twelve-month price targets for Gerresheimer in the last year. Their average twelve-month price target is $88.97, suggesting a possible upside of 36.5%.
View the latest price targets for GRRMF.

What is the current consensus analyst rating for Gerresheimer?

Gerresheimer currently has 1 hold rating and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe GRRMF will outperform the market and that investors should add to their positions of Gerresheimer.
View the latest ratings for GRRMF.

How do I contact Gerresheimer's investor relations team?

Gerresheimer's physical mailing address is Klaus-Bungert-Strasse 4, Dusseldorf, Nordrhein-Westfalen 40468. The company's listed phone number is 49 211 6181 00. The official website for Gerresheimer is www.gerresheimer.com. Learn More about contacing Gerresheimer investor relations.